Uganda - engleski - National Drug Authority

wilshire laboratories (pvt) ltd - metformin hydrochloride+ sitagliptin monohydrate phosphate - oral solid ordinary film-coated tablets - 1000mg + 50mg

Uganda - engleski - National Drug Authority

wilshire laboratories (pvt) ltd - azithromycin dihydrate - oral solid ordinary tablets - 250mg

Uganda - engleski - National Drug Authority

wilshire laboratories (pvt) ltd - azithromycin dihydrate - oral solid ordinary tablets - 500mg

Uganda - engleski - National Drug Authority

wilshire laboratories (pvt) ltd - pregabalin - oral solid ordinary other capsules - 75 mg

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

wilshire pharmaceuticals, inc. - dextroamphetamine sulfate (unii: jj768o327n) (dextroamphetamine - unii:tz47u051fi) - dextroamphetamine sulfate 5 mg - dextroamphetamine sulfate tablets, usp are indicated for: known hypersensitivity to amphetamine products. during or within 14 days following the administration of monoamine oxidase inhibitors (hypertensive crises may result). dextroamphetamine sulfate tablets are a schedule ii controlled substance. dextroamphetamine sulfate has a high potential for abuse and misuse which can lead to the development of a substance use disorder, including addiction (see warnings). dextroamphetamine sulfate can be diverted for non-medical use into illicit channels or distribution. abuse is the intentional non-therapeutic use of a drug, even once, to achieve a desired psychological or physiological effect. misuse is the intentional use, for therapeutic purposes, of a drug by an individual in a way other than prescribed by a health care provider or for whom it was not prescribed. drug addiction is a cluster of behavioral, cognitive, and physiological phenomena that may include a strong desire to take the drug, difficulties in con

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

wilshire pharmaceuticals - amphetamine sulfate (unii: 6dpv8nk46s) (amphetamine - unii:ck833kgx7e) - amphetamine sulfate tablets, usp, are indicated for: - narcolepsy - attention deficit disorder with hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of the syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or not be warranted. - exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction for patient's refractory to alternative therapy, e.g., repeated diets, group programs, an

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

wilshire pharmaceuticals inc. - erythromycin ethylsuccinate (unii: 1014ksj86f) (erythromycin - unii:63937kv33d) - erythromycin 200 mg in 5 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of erythromycin ethylsuccinate and other antibacterial drugs, erythromycin ethylsuccinate should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. erythromycin ethylsuccinate is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the diseases listed below: upper respiratory tract infections of mild to moderate degree caused by streptococcus pyogenes , streptococcus pneumoniae , or haemophilus influenzae (when used concomitantly with adequate doses of sulfonamides, since many strains of h. influenza e are not susceptible to the erythromycin concentrati

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

wilshire pharmaceuticals, inc. - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine hydrochloride tablets are indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. tiagabine hydrochloride tablets are contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of tiagabine hydrochloride have not been evaluated in human studies.

Kenija - engleski - Pharmacy and Poisons Board

q pharma dmcc unit no: 2681 dmcc business centre level no 1. p. - apixaban - tablet - apixaban 2.5mg - apixaban

Kenija - engleski - Pharmacy and Poisons Board

q pharma dmcc unit no: 2681 dmcc business centre level no 1,p. - apixaban - tablet - apixaban 5mg - apixaban